Compare Medtronic PLC (MDT) vs Target Corporation (TGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Target Corporation — how do they compare? Medtronic PLC trades at $88.06 (market cap $112.24B), while Target Corporation trades at $154.87 (market cap $70.31B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Target Corporation for 137 Days on average.
| MDT | TGT | |
|---|---|---|
Market Cap | $112.24B | $70.31B |
Volume | 105,663,236 | 4,164,999 |
Sector | Health | Consumer Staples |
52-Week High | $105.35 | $169.90 |
52-Week Low | $73.75 | $83.68 |
Typical Hold Time | 63 Days | 137 Days |
Enterprise Value | $131.58B | $83.58B |
Dividend Yield | 3.28% | 3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
Target Corporation (TGT) trades at $154.56, up 2.38% with strong recent earnings beats and positive analyst sentiment. The stock shows bearish technical signals but maintains solid fundamentals with a 4.08% net margin and 26.41% ROE. Recent price cuts on 2,000 items aim to capture holiday market share, while consistent dividend payments reinforce shareholder returns. Valuation metrics appear reasonable with P/E of 16.05 and P/S of 0.65.
Target presents a balanced opportunity with analyst consensus pointing to 8% upside to the $167.18 price target. The turnaround strategy shows early success, but competitive pressures and margin compression from price investments remain key risks. Institutional support remains strong with 60 analyst coverage favoring buy/hold positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →
